About Hemanext
Learn more about Hemanext to envision a world with fewer, better transfusions.
Who We Are
Hemanext is a medical technology company with corporate headquarters in Lexington, MA and manufacturing operations in Avon, MA. Our corporate mission is to support the transfusion medicine community in its efforts to save lives and improve patient outcomes. Our distinctive focus is on innovations that promote dramatic improvements in transfusion therapy.
Our current focus is on:
Hemanext ONE®
An innovative storage system for red blood cells. This technology has been developed with funding from private investors as well as grants and development contracts from the National Institutes of Health.
The Hemanext ONE® System has not been cleared or approved by FDA or any regulatory agency for commercial distribution.
Our Science
Stored Blood
The average human body stores about 5.6 liters of blood. As it circulates through the body several times each minute, it accomplishes a variety of functions.
Storage Lesion
Clinical Implications
Numerous studies pertaining to clinical implications of storage lesion suggest a linkage to hyper-coagulability, inflammation, impaired perfusion, immuno-modulation, organ dysfunction13, and mortality14.
